Bicycle Therapeutics PLC (BCYC)
20.46
-1.33
(-6.10%)
USD |
NASDAQ |
Nov 18, 16:00
20.48
+0.02
(+0.10%)
After-Hours: 20:00
Bicycle Therapeutics Market Cap: 1.413B for Nov. 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2024 | 1.413B |
| November 15, 2024 | 1.505B |
| November 14, 2024 | 1.559B |
| November 13, 2024 | 1.603B |
| November 12, 2024 | 1.617B |
| November 11, 2024 | 1.679B |
| November 08, 2024 | 1.723B |
| November 07, 2024 | 1.705B |
| November 06, 2024 | 1.632B |
| November 05, 2024 | 1.623B |
| November 04, 2024 | 1.620B |
| November 01, 2024 | 1.568B |
| October 31, 2024 | 1.619B |
| October 30, 2024 | 1.659B |
| October 29, 2024 | 1.690B |
| October 28, 2024 | 1.712B |
| October 25, 2024 | 1.707B |
| October 24, 2024 | 1.710B |
| October 23, 2024 | 1.747B |
| October 22, 2024 | 1.809B |
| October 21, 2024 | 1.843B |
| October 18, 2024 | 1.866B |
| October 17, 2024 | 1.845B |
| October 16, 2024 | 1.899B |
| October 15, 2024 | 1.870B |
| Date | Value |
|---|---|
| October 14, 2024 | 1.808B |
| October 11, 2024 | 1.826B |
| October 10, 2024 | 1.728B |
| October 09, 2024 | 1.696B |
| October 08, 2024 | 1.624B |
| October 07, 2024 | 1.615B |
| October 04, 2024 | 1.629B |
| October 03, 2024 | 1.532B |
| October 02, 2024 | 1.557B |
| October 01, 2024 | 1.567B |
| September 30, 2024 | 1.562B |
| September 27, 2024 | 1.601B |
| September 26, 2024 | 1.609B |
| September 25, 2024 | 1.611B |
| September 24, 2024 | 1.628B |
| September 23, 2024 | 1.654B |
| September 20, 2024 | 1.753B |
| September 19, 2024 | 1.759B |
| September 18, 2024 | 1.681B |
| September 17, 2024 | 1.684B |
| September 16, 2024 | 1.723B |
| September 13, 2024 | 1.864B |
| September 12, 2024 | 1.879B |
| September 11, 2024 | 1.860B |
| September 10, 2024 | 1.865B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
137.49M
Minimum
Dec 09 2019
1.899B
Maximum
Oct 16 2024
812.23M
Average
738.06M
Median
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 152.25M |
| NuCana PLC | 3.235M |
| TC BioPharm (Holdings) PLC | 0.3021M |
| Autolus Therapeutics PLC | 795.70M |
| Biodexa Pharmaceuticals PLC | 2.120M |
Market Cap Related Metrics
| PS Ratio | 28.56 |
| Price to Book Value | 1.700 |
| Price | 20.46 |
| Earnings Yield | -16.08% |